contract-review

To review a clinical trial EDC software agreement for SLA compliance, analyze the scope of services, data ownership, and liability clauses against industry standards. This process identifies risk areas and suggests modifications to ensure proper data handling.

The best way to identify risk areas in clinical trial contracts is by comparing scope, IP, and termination clauses against established company templates. This highlights deviations in data ownership, SLAs, and liability to pinpoint unfavorable terms.

To check if a vendor contract meets company standards for clinical trials, analyze the agreement's compliance and SLA terms against your internal templates. This comparison flags deviations and provides actionable recommendations for improving contract language.

Yes, you can get modification suggestions for data handling clauses in EDC agreements by analyzing the contract against industry standards. The review provides actionable recommendations to improve language related to data ownership, IP, and liability.

You need to analyze termination and liability clauses in clinical trial software agreements whenever a new client submits a standard vendor agreement. This review protects company interests by flagging deviations from established SLA and compliance standards.

A limitation when reviewing clinical trial contracts for risk management is that analysis is limited to the text provided in the agreement and company templates. It cannot assess external compliance factors or verify actual service delivery against SLA promises.